Arantxa Valdivia
Papers
1
Total Citations
11
H-Index
1
About
Arantxa Valdivia has made pivotal contributions to the field of molecular diagnostics, with a primary focus on enhancing the accuracy of SARS-CoV-2 detection. Her key research areas encompass virology, diagnostic assay optimization, and the molecular mechanisms underlying false-negative results in infectious disease testing. Valdivia’s most notable work, "Amplification of human β‐glucuronidase gene for appraising the accuracy of negative SARS‐CoV‐2 RT‐PCR results in upper respiratory tract specimens" (2020, 11 citations), addresses a critical challenge in COVID-19 diagnosis: the high rate of false negatives, which can reach up to 30% in clinically suspected cases. By leveraging the human β-glucuronidase gene as an internal control, she developed a method to evaluate the reliability of negative RT-PCR results, thereby improving diagnostic confidence and patient management. This contribution has been instrumental in refining testing protocols during the pandemic, underscoring her impact on public health. Valdivia’s work demonstrates a keen ability to bridge molecular biology and clinical application, offering practical solutions to pressing diagnostic dilemmas. Her research continues to influence best practices in virological testing, making her a valuable voice in the ongoing effort to combat infectious diseases.
Research Focus
Key Achievements
Top Papers
- 1